首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Prognostic values of soluble CD30 and CD30 gene polymorphisms in heart transplantation.
【24h】

Prognostic values of soluble CD30 and CD30 gene polymorphisms in heart transplantation.

机译:可溶性CD30和CD30基因多态性在心脏移植中的预后价值。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Pretransplant soluble CD30 (sCD30) is a predictor of kidney graft outcome. Its status as a predictor of heart transplant (HT) outcome has not been established. We have studied this question by assessing sCD30 levels and the number of (CCAT)n repeats of the microsatellite in the CD30 promoter region, which is able alone to repress gene transcription, in the sera of 83 HT patients and 77 of their donors. sCD30 was non-significantly increased in the patients, whereas there were no differences in the CD30 microsatellite allele frequencies. A negative correlation between the number of (CCAT)n and sCD30 levels was evident in the donors. Patients with pretransplant sCD30
机译:移植前可溶性CD30(sCD30)是肾移植结果的预测指标。尚未确定其作为心脏移植(HT)结果的预测指标的地位。我们通过评估83位HT患者及其77位供体的血清中sCD30水平和CD30启动子区域中微卫星的(CCAT)n重复数目(仅能抑制基因转录)来研究此问题。 sCD30在患者中没有显着增加,而CD30微卫星等位基因频率没有差异。在供体中,(CCAT)n数量与sCD30水平之间呈负相关。移植前sCD30 <或= 30 U / ml的患者表现出明显更好的存活率。总之,sCD30水平可预测HT结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号